Advanced search
Publication Cover
Clinical Toxicology Volume 52, 2014 - Issue 5
Submit an article Journal homepage
818
Views
79
CrossRef citations to date
0
Altmetric
Research Article

Two cases of severe intoxication associated with analytically confirmed use of the novel psychoactive substances 25B-NBOMe and 25C-NBOMe

M. H. Y. TangHospital Authority Toxicology Reference Laboratory, Princess Margaret Hospital, Hong Kong, P. R. China
,
C. K. ChingHospital Authority Toxicology Reference Laboratory, Princess Margaret Hospital, Hong Kong, P. R. China
,
M. S. H. TsuiAccident & Emergency Department, Queen Mary Hospital, Hong Kong, P. R. China
,
F. K. C. ChuAccident & Emergency Department, Queen Elizabeth Hospital, Hong Kong, P. R. China
&
T. W. L. MakHospital Authority Toxicology Reference Laboratory, Princess Margaret Hospital, Hong Kong, P. R. ChinaCorrespondence[email protected]
Pages 561-565 | Received 05 Feb 2014, Accepted 25 Mar 2014, Published online: 29 Apr 2014

References

  • Davis GG. Drug abuse: newly-emerging drugs and trends. Clin Lab Med 2012; 32:407–414.
  • Nelson ME, Bryant SM, Aks SE. Emerging drugs of abuse. Emerg Med Clin North Am 2014; 32:1–28.
  • Shulgin A, Shulgin A. PIHKAL: A Chemical Love Story. Berkeley, CA: Transform Press; 2011.
  • Dean BV, Stellpflug SJ, Burnett AM, Engebretsen KM. 2C or not 2C: phenethylamine designer drug review. J Med Toxicol 2013; 9: 172–178.
  • Hill SL, Thomas SH. Clinical toxicology of newer recreational drugs. Clin Toxicol (Phila) 2011; 49:705–719.
  • Curtis B, Kemp P, Harty L, Choi C, Christensen D. Postmortem identification and quantitation of 2,5-dimethoxy-4-n-propylthiophenethylamine using GC-MSD and GC-NPD. J Anal Toxicol 2003; 27:493–498.
  • Miyajima M, Matsumoto T, Ito S. 2C-T-4 intoxication: acute psychosis caused by a designer drug. Psychiatry Clin Neurosci 2008; 62:243.
  • Topeff JM, Ellsworth H, Willhite LA, Bangh SA, Edwards EM, Cole JB. A case series of symptomatic patients including one fatality following 2C-E exposure. Clin Toxicol (Phila) 2011; 40:526.
  • Hill SL, Doris T, Gurung S, Katebe S, Lomas A, Dunn M, et al. Severe clinical toxicity associated with analytically confirmed recreational use of 25I-NBOMe: case series. Clin Toxicol (Phila) 2013; 51:487–492.
  • Poklis JL, Nanco CR, Troendle MM, Wolf CE, Poklis A. Determination of 4-bromo-2,5-dimethoxy-N-[(2-methoxyphenyl)methyl]-benzeneethanamine (25B-NBOMe) in serum and urine by high performance liquid chromatography with tandem mass spectrometry in a case of severe intoxication. Drug Test Anal 2013; doi:10.1002/dta.1522.
  • Zuba D, Sekula K, Buczek A. 25C-NBOMe–new potent hallucinogenic substance identified on the drug market. Forensic Sci Int 2013; 227:7–14.
  • Braden MR, Parrish JC, Naylor JC, Nichols DE. Molecular interaction of serotonin 5-HT2A receptor residues Phe339(6.51) and Phe340(6.52) with superpotent N-benzyl phenethylamine agonists. Mol Pharmacol 2006; 70:1956–1964.
  • Lobos M, Borges Y, Gonzalez E, Cassels BK. The action of the psychoactive drug 2C-B on isolated rat thoracic aorta. Gen Pharmacol 1992; 23:1139–1142.
  • Saez P, Borges Y, Gonzalez E, Cassels BK. Alpha-adrenergic and 5-HT2-serotonergic effects of some beta-phenylethylamines on isolated rat thoracic aorta. Gen Pharmacol 1994; 25:211–216.
  • Kelly A, Eisenga B, Riley B, Judge B. Case series of 25I-NBOMe exposures with laboratory confirmation. Clin Toxicol (Phila) 2012; 50:702.
  • Poklis JL, Charles J, Wolf CE, Poklis A. High-performance liquid chromatography tandem mass spectrometry method for the determination of 2CC-NBOMe and 25I-NBOMe in human serum. Biomed Chromatogr 2013; 27:1794–1800.
  • Poklis JL, Devers KG, Arbefeville EF, Pearson JM, Houston E, Poklis A. Postmortem detection of 25I-NBOMe [2-(4-iodo-2, 5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine] in fluids and tissues determined by high performance liquid chromatography with tandem mass spectrometry from a traumatic death. Forensic Sci Int 2013; doi:10.1016/j.forsciint.2013.10.015.
  • Rose RS, Cumpston KL, Stromberg PE, Wills BK. Severe poisoning following self-reported use of 25I, a novel substituted amphetamine. Clin Toxicol (Phila) 2012; 50:707.
  • Rose SR, Poklis JL, Poklis A. A case of 25I-NBOMe (25-I) intoxication: a new potent 5-HT2A agonist designer drug. Clin Toxicol (Phila) 2013; 51:174–177.
  • Sporkert F, Augsburger M, Vilarino R, Michaud K, Schlapfer M, Marcourt L. Identification and implication of the phenethylamine derivative 25B-NBOMe in a case of an unresolved fatality. 51st Annual Meeting of the International Association of Forensic Toxicologists; 2013.
  • Stellpflug SJ, Kealey SE, Hegarty CB, Janis GC. 2-(4-Iodo-2, 5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe): clinical case with unique confirmatory testing. J Med Toxicol 2013; doi:10.1007/s13181-013-0314-y.
  • Drug Enforcement Administration. Department of Justice. Schedules of controlled substances: temporary placement of three synthetic phenethylamines into Schedule I. Final order. Fed Regist 2013; 78:68716–68719.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.